Plasma neutrophil elastase and elafin imbalance is associated with Acute Respiratory Distress Syndrome (ARDS) development

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Wang, Zhaoxi ^a   Chen, Feng ^a   Zhai, Rihong ^a   Zhang, Lingsong ^a   Su, Li ^a   Lin, Xihong ^a   Thompson, Taylor ^b   Christiani, David C ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELAFIN; LEUKOCYTE ELASTASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PATIENT MONITORING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RESPIRATORY DISTRESS;

EID: 84887212587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004380     Document Type: Article

References (37)

1. Mortelliti MP, Manning HL (2002) Acute respiratory distress syndrome. Am Fam Physician 65: 1823-1830.
2. Frutos-Vivar F, Nin N, Esteban A (2004) Epidemiology of acute lung injury and acute respiratory distress syndrome. Curr Opin Crit Care 10: 1-6.
3. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824.
4. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, et al. (2002) Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161: 1783-1796.
5. Parsons PE, Matthay MA, Ware LB, Eisner MD (2005) Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 288: L426-431.
6. McClintock DE, Ware LB, Eisner MD, Wickersham N, Thompson BT, et al. (2007) Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. Am J Respir Crit Care Med 175: 256-262.
7. Wang Z, Beach D, Su L, Zhai R, Christiani DC (2008) A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol 38: 724-732.
8. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, et al. (1986) Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis 133: 218-225.
9. Kawabata K, Hagio T, Matsuoka S (2002) The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 451: 1-10.
10. Takahashi H, Nukiwa T, Basset P, Crystal RG (1988) Myelomonocytic cell lineage expression of the neutrophil elastase gene. J Biol Chem 263: 2543-2547.
11. Fouret P, du Bois RM, Bernaudin JF, Takahashi H, Ferrans VJ, et al. (1989) Expression of the neutrophil elastase gene during human bone marrow cell differentiation. J Exp Med 169: 833-845.
12. Rice WG, Weiss SJ (1990) Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 249: 178-181.
13. Schalkwijk J, Wiedow O, Hirose S (1999) The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem J 340 ( Pt 3): 569-577.
14. Moreau T, Baranger K, Dade S, Dallet-Choisy S, Guyot N, et al. (2008) Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 90: 284-295.
15. Nara K, Ito S, Ito T, Suzuki Y, Ghoneim MA, et al. (1994) Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin". J Biochem (Tokyo) 115: 441-448.
16. Guyot N, Zani ML, Maurel MC, Dallet-Choisy S, Moreau T (2005) Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase. Biochemistry 44: 15610-15618.
17. Sallenave JM, Donnelly SC, Grant IS, Robertson C, Gauldie J, et al. (1999) Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur Respir J 13: 1029-1036.
18. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, et al. (2005) Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33: 1191-1198.
19. Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, et al. (2005) - 308GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J 26: 382-389.
20. Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, et al. (2004) Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 125: 203-211.
21. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, et al. (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100: 1619-1636.
22. Zhai R, Zhou W, Gong MN, Thompson BT, Su L, et al. (2007) Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians. Crit Care Med 35: 893-898.
23. Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J (1994) Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 11: 733-741.
24. Pfundt R, Wingens M, Bergers M, Zweers M, Frenken M, et al. (2000) TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway. Arch Dermatol Res 292: 180-187.
25. Reid PT, Marsden ME, Cunningham GA, Haslett C, Sallenave JM (1999) Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type II alveolar epithelial cells. FEBS Lett 457: 33-37.
26. Abraham E (2003) Neutrophils and acute lung injury. Crit Care Med 31: S195-199.
27. Zeiher BG, Matsuoka S, Kawabata K, Repine JE (2002) Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med 30: S281-287.
28. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, et al. (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med 304: 192-196.
29. Idell S, Kucich U, Fein A, Kueppers F, James HL, et al. (1985) Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 132: 1098-1105.
30. Donnelly SC, MacGregor I, Zamani A, Gordon MW, Robertson CE, et al. (1995) Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 151: 1428-1433.
31. Rocker GM, Wiseman MS, Pearson D, Shale DJ (1989) Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal. Lancet 1: 120-123.
32. Fujishima S, Morisaki H, Ishizaka A, Kotake Y, Miyaki M, et al. (2007) Neutrophil elastase and systemic inflammatory response syndrome in the initiation and development of acute lung injury among critically ill patients. Biomed Pharmacother.
33. Gando S, Kameue T, Matsuda N, Sawamura A, Hayakawa M, et al. (2004) Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Inflammation 28: 237-244.
34. Kodama T, Yukioka H, Kato T, Kato N, Hato F, et al. (2007) Neutrophil elastase as a predicting factor for development of acute lung injury. Intern Med 46: 699-704.
35. Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, et al. (2004) Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 32: 1695-1702.
36. Hoshi K, Kurosawa S, Kato M, Andoh K, Satoh D, et al. (2005) Sivelestat, a neutrophil elastase inhibitor, reduces mortality rate of critically ill patients. Tohoku J Exp Med 207: 143-148.
37. Hashimoto S, Okayama Y, Shime N, Kimura A, Funakoshi Y, et al. (2008) Neutrophil elastase activity in acute lung injury and respiratory distress syndrome. Respirology 13: 581-584.